CNX
71
2
CMI
60
-4
HSY
45
-6
CI
40
-5
ABT
56
2
PFE
26
-6
AME
59
-3
TAP
64
-2
GOOGL
67
8
WHR
72
-4
WYNN
30
-3
SYK
59
2
HUM
41
-2
FRT
39
-4
FITB
46
-2
BXP
52
-3
APH
61
-6
LB
12
11
LNC
29
-4
EXPD
50
7
CNX
71
2
CMI
60
-4
HSY
45
-6
CI
40
-5
ABT
56
2
PFE
26
-6
AME
59
-3
TAP
64
-2
GOOGL
67
8
WHR
72
-4
WYNN
30
-3
SYK
59
2
HUM
41
-2
FRT
39
-4
FITB
46
-2
BXP
52
-3
APH
61
-6
LB
12
11
LNC
29
-4
EXPD
50
7
Financhill
Back

Ocular Therapeutix Quote, Financials, Valuation and Earnings

Zero Day Options Trade LIVE Tuesday at 2 p.m. ET!

Discover The Zero Day Loophole (BEFORE Tues at 2 p.m. ET!)
Buy
63

OCUL
Ocular Therapeutix

Last Price:
9.56
Seasonality Move:
41.77%

7 Day Trial

ALL ACCESS PASS

$ 7

Better Than Oil Stocks

CLICK HERE TO FIND OUT MORE

Ocular Therapeutix Price Quote

$9.56
+0.12 (+1.27%)
(Updated: December 11, 2024 at 5:55 PM ET)

Ocular Therapeutix Key Stats

Buy
63
Ocular Therapeutix (OCUL) is a Buy
Day range:
$9.28 - $9.66
52-week range:
$3.25 - $11.78
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
21.32
P/B ratio:
4.22%
Volume:
606.8K
Avg. volume:
941.6K
1-year change:
160.77%
Market cap:
$1.5B
Revenue:
$58.4M
EPS:
$-1.32

How Much Does Ocular Therapeutix Make?

Is Ocular Therapeutix Growing As A Company?

  • What Is Ocular Therapeutix's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.02%
  • What Is Ocular Therapeutix's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Ocular Therapeutix Stock Price Performance

What Is Ocular Therapeutix 52-Week High & Low?

Ocular Therapeutix Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Ocular Therapeutix?

  • How Much Debt Does Ocular Therapeutix Have?
    Total long term debt quarterly is $67.8M
  • How Much Cash Does Ocular Therapeutix Have?
    Cash and short term investments quarterly total is $427.2M
  • What Is Ocular Therapeutix’s Book Value Per Share?
    Book value per share is 2.25

Is Ocular Therapeutix Cash Flow Positive?

  • What Is OCUL Cash Flow From Operations?
    Cash flow from operations (TTM) is -$117.7M
  • What Is Ocular Therapeutix’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $435.8M
  • What Is Ocular Therapeutix’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$1.5M

Ocular Therapeutix Return On Invested Capital

  • Is Management Doing A Good Job?
    OCUL return on invested capital is -54.93%
  • What Is Ocular Therapeutix Return On Assets?
    ROA measures how assets are converting to revenues and is -44.46%
  • What Is OCUL Return On Equity?
    ROE is a measure of profitability and is -70.49%

Ocular Therapeutix Earnings Date & Stock Price

Ocular Therapeutix Competitors

  • Who Are Ocular Therapeutix's Competitors?
    Below is a list of companies who compete with Ocular Therapeutix or are related in some way:
    • 4D Molecular Therapeutics Inc (FDMT)
    • iBio Inc (IBIO)
    • NovaBay Pharmaceuticals Inc (NBY)
    • Palatin Technologies Inc (PTN)
    • Theriva Biologics Inc (TOVX)

Ocular Therapeutix Dividend Yield

Ocular Therapeutix Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -6.45%
Revenue: 2.28% -10.01%

Analyst Recommendations

Buy Recommendations: 5
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 18.22
Upside from Last Price: 93.03%

Major Shareholders

  • How many OCUL shares are owned by institutional investors?
    193.3M OCUL shares are owned by institutional investors
  • How many OCUL shares are owned by insiders?
    4.9M OCUL shares are owned by insiders